Your browser is no longer supported. Please, upgrade your browser.
TMO [NYSE]
Thermo Fisher Scientific Inc.
IndexS&P 500 P/E27.53 EPS (ttm)21.55 Insider Own0.10% Shs Outstand394.00M Perf Week-4.37%
Market Cap236.21B Forward P/E27.10 EPS next Y21.89 Insider Trans-30.12% Shs Float393.23M Perf Month-8.86%
Income8.56B PEG2.33 EPS next Q5.23 Inst Own90.10% Short Float0.64% Perf Quarter0.21%
Sales39.06B P/S6.05 EPS this Y73.80% Inst Trans0.01% Short Ratio1.77 Perf Half Y15.38%
Book/sh98.25 P/B6.04 EPS next Y-7.79% ROA12.40% Target Price691.41 Perf Year15.03%
Cash/sh- P/C- EPS next 5Y11.80% ROE23.60% 52W Range433.52 - 672.34 Perf YTD-11.07%
Dividend1.04 P/FCF31.34 EPS past 5Y26.50% ROI12.30% 52W High-11.81% Beta0.77
Dividend %0.18% Quick Ratio2.60 Sales past 5Y13.70% Gross Margin51.10% 52W Low36.77% ATR15.36
Employees80000 Current Ratio3.20 Sales Q/Q9.50% Oper. Margin27.00% RSI (14)35.49 Volatility2.49% 2.35%
OptionableYes Debt/Eq0.56 EPS Q/Q-1.10% Profit Margin21.90% Rel Volume0.81 Prev Close593.37
ShortableYes LT Debt/Eq0.56 EarningsFeb 02 BMO Payout4.40% Avg Volume1.42M Price592.91
Recom1.80 SMA20-6.03% SMA50-6.53% SMA2007.04% Volume1,078,468 Change-0.08%
Oct-20-21Upgrade Citigroup Neutral → Buy $620 → $700
Oct-15-21Resumed Cowen Outperform $655 → $696
Aug-05-21Resumed Credit Suisse Outperform $580
Jul-16-21Initiated The Benchmark Company Buy $580
Mar-18-21Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Mar-03-21Initiated Barclays Overweight $525
Jan-08-21Upgrade Credit Suisse Neutral → Outperform $490 → $556
Dec-16-20Downgrade Citigroup Buy → Neutral $550 → $500
Dec-02-20Initiated Goldman Buy $570
Nov-10-20Initiated KeyBanc Capital Markets Sector Weight $550
Sep-30-20Initiated Atlantic Equities Overweight $494
Sep-14-20Initiated Morgan Stanley Overweight $485
Aug-20-20Resumed JP Morgan Overweight $460
Jul-15-20Upgrade Cleveland Research Neutral → Buy
Jul-07-20Reiterated Needham Buy $383 → $415
Apr-23-20Reiterated Needham Buy $341 → $383
Jan-31-20Reiterated Needham Buy $331 → $341
Jan-22-20Initiated Credit Suisse Neutral $341
Jan-08-20Initiated Wells Fargo Equal Weight $350
Jan-07-20Initiated Citigroup Buy $380
Jan-20-22 01:38PM  
05:36AM  
Jan-19-22 05:38PM  
05:38PM  
09:38AM  
Jan-17-22 09:04AM  
04:31AM  
Jan-14-22 09:38AM  
Jan-13-22 06:52AM  
Jan-12-22 05:50PM  
Jan-11-22 09:32AM  
Jan-10-22 01:38PM  
Jan-07-22 12:10PM  
11:58AM  
Jan-06-22 05:50PM  
01:15PM  
12:03PM  
11:58AM  
09:45AM  
09:01AM  
Jan-05-22 11:35AM  
11:07AM  
10:30AM  
10:28AM  
09:35AM  
08:00AM  
07:59AM  
07:59AM  
07:57AM  
07:16AM  
Jan-04-22 09:46AM  
09:33AM  
08:50AM  
08:00AM  
07:42AM  
Jan-03-22 09:38PM  
04:00PM  
10:30AM  
10:05AM  
08:30AM  
08:11AM  
Dec-31-21 05:50PM  
10:05AM  
08:32AM  
Dec-30-21 04:05PM  
11:07AM  
Dec-29-21 06:00PM  
01:47PM  
11:27AM  
11:27AM  
11:05AM  
10:11AM  
Dec-28-21 11:02AM  
10:04AM  
09:25AM  
09:15AM  
07:40AM  
Dec-27-21 11:20AM  
11:07AM  
10:37AM  
10:21AM  
10:05AM  
08:15AM  
08:11AM  
Dec-25-21 10:38PM  
Dec-24-21 11:31AM  
11:31AM  
07:54AM  
07:40AM  
Dec-23-21 05:50PM  
12:38PM  
11:15AM  
10:46AM  
10:26AM  
10:04AM  
09:01AM  
08:04AM  
08:03AM  
Dec-22-21 06:00PM  
03:30PM  
12:13PM  
11:08AM  
10:22AM  
09:54AM  
09:53AM  
08:54AM  
07:56AM  
07:56AM  
Dec-21-21 12:22PM  
10:57AM  
10:45AM  
10:17AM  
09:50AM  
08:05AM  
Dec-20-21 12:27PM  
12:15PM  
10:57AM  
10:50AM  
10:48AM  
10:15AM  
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stevenson MarkExecutive Vice President & COODec 01Option Exercise175.4626,9254,724,37486,181Dec 03 04:16 PM
Stevenson MarkExecutive Vice President & COODec 01Sale631.8826,92517,013,31059,256Dec 03 04:16 PM
Williamson StephenSr. VP and CFONov 02Option Exercise129.7722,5502,926,31462,771Nov 03 04:34 PM
Stevenson MarkExecutive Vice President & COONov 02Option Exercise175.4626,9254,724,37486,181Nov 03 04:36 PM
Stevenson MarkExecutive Vice President & COONov 02Sale638.0326,92517,179,05459,256Nov 03 04:36 PM
Williamson StephenSr. VP and CFONov 02Sale638.1022,55014,389,04540,221Nov 03 04:34 PM
Stevenson MarkExecutive Vice President & COONov 01Option Exercise175.4626,9254,724,37486,181Nov 03 04:36 PM
Stevenson MarkExecutive Vice President & COONov 01Sale632.6926,92517,035,09359,256Nov 03 04:36 PM
Holmes Joseph R.VP & Chief Accounting OfficerAug 09Option Exercise198.21759150,4401,372Aug 10 04:18 PM
Holmes Joseph R.VP & Chief Accounting OfficerAug 09Sale542.75759411,948897Aug 10 04:18 PM
CASPER MARC NChairman & CEOAug 05Sale539.9310,0005,399,345189,060Aug 06 04:29 PM
CASPER MARC NChairman & CEOAug 04Sale539.0510,0005,390,468199,060Aug 06 04:29 PM
CASPER MARC NChairman & CEOAug 03Sale535.7310,0005,357,276209,060Aug 04 04:25 PM
Stevenson MarkExecutive Vice President & COOAug 02Option Exercise175.4626,9254,724,37489,279Aug 04 04:22 PM
CASPER MARC NChairman & CEOAug 02Sale535.4610,0005,354,584219,060Aug 04 04:25 PM
Stevenson MarkExecutive Vice President & COOAug 02Sale535.3826,92514,415,22062,354Aug 04 04:22 PM
MANZI JIM PDirectorJul 30Sale536.54572306,89917,752Aug 02 04:05 PM
Lagarde MichelExecutive Vice PresidentMay 10Option Exercise190.5921,6004,116,74440,061May 11 04:44 PM
Lagarde MichelExecutive Vice PresidentMay 10Sale464.5121,60010,033,51818,461May 11 04:44 PM
Lagarde MichelExecutive Vice PresidentMay 07Option Exercise190.5929,1005,546,16952,629May 11 04:44 PM
Lagarde MichelExecutive Vice PresidentMay 07Sale472.6034,16816,147,63618,461May 11 04:44 PM
Lagarde MichelExecutive Vice PresidentFeb 12Sale507.797,2903,701,78915,775Feb 17 04:01 PM